Indian billionaire investor Rakesh Jhunjhunwala says he's very upbeat about his country's growth potential after the country underwent a massive banking crisis and the rollout...Asia Economyread more
Stocks in Asia mostly recovered in Tuesday afternoon trade as investors cheered a reprieve in U.S.-China trade tensions surrounding Chinese telecommunications giant Huawei.Asia Marketsread more
The issue of corporate debt has surfaced as companies continue to use the low rates the Fed has provided to lever up their balance sheets.The Fedread more
The U.S. government on Monday temporarily eased some trade restrictions imposed recently on China's Huawei, a move that sought to minimize disruption for the telecom company's...Technologyread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
Mall owners are increasingly building out food halls with local chef-driven eateries, sushi bars and premium coffee shops.Retailread more
While Trump's lawyers had argued that the committee's subpoena did not have a legitimate legislative purpose — and was therefore invalid — Mehta took a broader view.Politicsread more
See which stocks are posting big moves after the bell on Monday, May 20.Market Insiderread more
A record 257.4 million travelers are expected to opt for U.S. airlines for travel this summer, the 10th consecutive annual increase, a trade group forecast on Tuesday.Airlinesread more
Binny Bansal, co-founder of Indian e-commerce giant Flipkart, says there are three traits that led to the business landing a record-breaking sale to retail giant Walmart.Entrepreneursread more
Silicon Valley argues that Wall Street focuses too much on near-term profits — but investors have embraced money-losing biotech IPOs.Marketsread more
A jury has ordered Aetna to pay more than $25 million to the family of an Oklahoma City woman who died a year after the insurance company refused to cover a type of radiation therapy.
Jurors found that Aetna doctors didn't spend enough time reviewing Orrana Cunningham's case before denying her coverage for proton beam therapy in 2014, The Oklahoman reported . The jury ruled that Aetna recklessly disregarded its duty to deal fairly and in good faith with Cunningham, who had nasopharyngeal cancer.
Aetna is considering whether to appeal the ruling, which was issued this week. Company attorney John Shely said the insurer tries to do the right thing.
"If it's in our control to change, that's what we're going to do," Shely said. "Aetna has learned something here."
An Aetna doctor denied Cunningham coverage for the therapy in 2014, deeming it experimental. Two other in-house doctors reviewed and upheld the decision.
The Food and Drug Administration had approved proton beam therapy, which is also a treatment covered by Medicare, according to Doug Terry, the family's attorney. He alleged that Aetna denied coverage for financial reasons and that its doctors were unqualified, overworked and biased when making decisions. Court records show that one doctor complained to the insurer about having to review more than 80 cases a day.
After she was denied coverage, Cunningham and her husband decided to mortgage their home in Meeker, about 35 miles (56 kilometers) east of Oklahoma City, to pay for the therapy in Texas. She died in May 2015 at age 54.
"My wife, her goal, was to make this fight," Ron Cunningham said. "Her comment was, 'If we can save one person and stop Aetna from doing what they traditionally do on every claim, it was worth the battle.'"